Latest News

Changes to EMA registration process for SMEs

22/11/2011

The European Medicines Agency (EMA) has recently made changes to its process for the registration of micro, small or medium-sized enterprises (SMEs) which are expected to reduce the administrative burden on companies and to speed up the SME assignment and renewal process.  The financial incentives and support available to registered companies are significant and companies should be encouraged to consider their eligibility from the outset in any European regulatory strategy. 

Wainwright Associates are experts in assisting eligible companies achieve SME status and supporting them throughout all phases of product development, regulatory affairs, pharmacovigilance and licensing.  To discuss your requirements, contact us at enquiries@wainwrightassociates.co.uk or telephone +44 (0)1628 530554.